White & Case Leads EQT In $654M Karo Pharma Bid
Private equity firm EQT, advised by White & Case LLP, on Monday offered to take Karo Pharma private for 5.97 billion Swedish krona ($653.5 million), as the Swiss specialty pharmaceutical company...To view the full article, register now.
Already a subscriber? Click here to view full article